General Report Contents
• Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
• Market Drivers & Limiters for each chapter segment
• Competitive Analysis for each chapter segment
• Section on recent mergers & acquisitions
The da Vinci® system was used in India to perform the country’s first robotically-assisted procedure in 2002. The system is currently used to perform a wide variety of procedures including urologic, general laparoscopic, gynecologic laparoscopic, general non-cardiovascular thoracoscopic and thoracoscopically assisted cardiotomy surgical procedures in children and adults. Because medical robotic systems require a long and costly development phase, there are currently no competitive systems on the market, however, there are many prototypes.
'
TABLE OF CONTENTS I
LIST OF FIGURES XXI
LIST OF CHARTS XXVI
EXECUTIVE SUMMARY 1
INDIA ROBOTICS AND SURGICAL NAVIGATION MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 6
MARKET DEVELOPMENTS 8
MARKETS INCLUDED 9
KEY REPORT UPDATES 10
PROCEDURES 11
VERSION HISTORY 12
RESEARCH METHODOLOGY 13
1.1 RESEARCH SCOPE 13
1.2 IDATA’S 9-STEP METHODOLOGY 13
Step 1: Project Initiation & Team Selection 13
Step 2: Prepare Data Systems and Perform Secondary Research 15
Step 3: Preparation for Interviews & Questionnaire Design 16
Step 4: Performing Primary Research 17
Step 5: Research Analysis: Establishing Baseline Estimates 19
Step 6: Market Forecast and Analysis 20
Step 7: Identify Strategic Opportunities 22
Step 8: Final Review and Market Release 23
Step 9: Customer Feedback and Market Monitoring 24
DISEASE OVERVIEW 25
2.1 MEDICAL CONDITIONS 25
2.1.1 Neurosurgery Conditions 25
2.1.1.1 Hydrocephalus 25
2.1.1.2 Communicating Hydrocephalus 25
2.1.1.3 Normal Pressure Hydrocephalus 26
2.1.1.4 Non-Communicating Hydrocephalus 26
2.1.1.5 Brain Tumor 26
2.1.1.6 Intracranial Pressure 26
2.1.1.7 Intracranial Aneurysm 26
2.1.1.8 Intracranial Atherosclerosis Disease 26
2.1.2 Spinal Conditions 28
2.1.2.1 Herniated Disc 28
2.1.2.2 Spinal Stenosis 28
2.1.2.3 Spondylosis 28
2.1.2.4 Scoliosis 28
2.1.2.5 Lordosis 28
2.1.2.6 Kyphosis 29
2.1.3 ENT Conditions 30
2.1.3.1 Otitis Media 30
2.1.3.2 Cholesteatomas 30
2.1.3.3 Otosclerosis 30
2.1.3.4 Chronic Sinusitis 30
2.1.3.5 Tonsillitis 30
2.1.4 Orthopedic Conditions 31
2.1.4.1 Fractures 31
2.1.4.2 Osteoporosis 31
2.1.4.3 Arthritis 31
2.1.5 Gynecological Conditions 31
2.1.5.1 Gynecological Cancers 31
2.1.5.2 Uterine Fibroids 32
2.1.5.3 Endometriosis 32
2.1.5.4 Menorrhagia 32
2.1.5.5 Pelvic Prolapse 32
2.1.6 Urological Conditions 34
2.1.6.1 Prostate Cancer 34
2.1.6.2 Bladder Cancer 34
2.1.6.3 Kidney Cancer 34
2.1.6.4 Benign Prostate Hyperplasia (BPH) 35
2.1.7 Digestive Tract Conditions 36
2.1.7.1 Achalasia 36
2.1.7.2 Stomach Cancer 36
2.1.7.3 Hernia 36
2.1.7.4 Gallbladder Attack 36
2.1.7.5 Gastroesophageal Reflex Disease 37
2.1.8 Colorectal Conditions 38
2.1.8.1 Colorectal Cancer 38
2.1.8.2 Inflammatory Bowel Disease 38
2.1.8.3 Diverticulitis 38
2.1.9 Cardiac Conditions 40
2.1.9.1 Mitral Valve Prolapse 40
2.1.9.2 Coronary Artery Disease 40
PRODUCT ASSESSMENT 41
3.1 RAS PRODUCT PORTFOLIOS 41
3.1.1 Robotic-Assisted Surgery Overview 41
3.1.2 Minimally Invasive Surgery 42
3.1.3 Orthopedic Surgery 43
3.1.4 Neurosurgery 45
3.1.5 Spine Surgery 46
3.1.6 Radiosurgery 47
3.2 ROBOTIC ASSISTED SURGERY REGULATORY ISSUES AND RECALLS 48
3.2.1 Accuray Inc. 48
3.2.2 Blue Belt Technologies 50
3.2.3 Hansen Medical Inc. 51
3.2.4 Intuitive Surgical 52
3.2.5 MAKO Surgical/Stryker 70
3.2.6 OMNIlife Science 72
3.3 CLINICAL TRIALS 74
3.4 RAS CLINICAL TRIALS 75
3.4.1 Accuray Inc. 75
3.4.2 Intuitive Surgical 81
3.4.3 MAKO Surgical/Stryker 84
3.4.4 Mazor 87
3.4.5 Medrobotics 90
3.4.6 Medtech 91
INDIA SURGICAL ROBOTICS MARKET 92
4.1 INTRODUCTION 92
4.2 MINIMALLY INVASIVE SURGERY ROBOTIC DEVICE MARKET 94
4.2.1 Introduction 94
4.2.2 Market Analysis and Forecast 95
4.2.3 Drivers and Limiters 99
4.2.3.1 Market Drivers 99
4.2.3.2 Market Limiters 99
4.2.4 Leading Competitors 101
4.2.5 Emerging Competitors 102
4.3 ROBOTIC ASSISTED ORTHOPEDIC SURGERY MARKET 103
4.3.1 Introduction 103
4.3.2 Market Analysis and Forecast 103
4.3.3 Drivers and Limiters 107
4.3.3.1 Market Drivers 107
4.3.3.2 Market Limiters 107
4.3.4 Emerging Competitors 110
APPENDIX I: ROBOTIC ASSISTED NEUROSURGERY, SPINE, AND RADIOSURGERY MARKETS 112
5.1 INTRODUCTION 112
5.2 MARKET ANALYSIS AND FORECAST 114
5.3 DRIVERS AND LIMITERS 116
5.3.1 Market Drivers 116
5.3.2 Market Limiters 117
5.4 LEADING COMPETITORS 119
ABBREVIATIONS 121
APPENDIX II: COMPETITOR PRESS RELEASES 123
Chart 1 1: Robotics and Surgical Navigation Market by Segment, India, 2013 – 2023 3
Chart 1 2: Robotics and Surgical Navigation Market Overview, India, 2016 & 2023 3
Chart 4 1: Minimally Invasive Surgery Robotic Device Market, India, 2013 – 2023 98
Chart 4 2: Robotic Assisted Orthopedic Surgery Market, India, 2013 – 2023 106
Figure 1 1: Robotics and Surgical Navigation Systems Competitor Market Share Ranking by Segment, India, 2016 (1 of 2) 4
Figure 1 2: Robotics and Surgical Navigation Systems Competitor Market Share Ranking by Segment, India, 2016 (2 of 2) 5
Figure 1 3: Companies Researched in this Report, India, 2016 5
Figure 1 4: Factors Impacting the Robotics and Surgical Navigation Systems Market by Segment, India (1 of 2) 6
Figure 1 5: Factors Impacting the Robotics and Surgical Navigation Systems Market by Segment, India (2 of 2) 7
Figure 1 6: Recent Events in the Robotics and Surgical Navigation Market, India, 2013 – 2016 8
Figure 1 7: Robotics and Surgical Navigation Markets Covered, India, 2016 9
Figure 1 8: Key Report Updates 10
Figure 1 9: Robotics and Surgical Navigation Systems Procedures Covered, U.S., 2016 (2 of 2) 12
Figure 1 10: Version History 12
Figure 3 1: Robot-Assisted Laparoscopy Products by Company 42
Figure 3 2: Robot-Assisted Orthopedic Surgery Products by Company 44
Figure 3 3: Robot-Assisted Neurosurgery Products by Company 45
Figure 3 4: Robot-Assisted Spine Surgery Products by Company 46
Figure 3 5: Robot-Assisted Radiosurgery Products by Company 47
Figure 3 6: Class 2 Device Recall Accuray Inc 48
Figure 3 7: Class 2 Device Recall Accuray Inc 48
Figure 3 8: Class 2 Device Recall Accuray Inc 48
Figure 3 9: Class 2 Device Recall Accuray Inc 49
Figure 3 10: Class 2 Device Recall Accuray Inc 49
Figure 3 11: Class 2 Device Recall Accuray Inc 49
Figure 3 12: Class 2 Device Recall Blue Belt Technologies 50
Figure 3 13: Class 2 Device Recall Blue Belt Technologies 50
Figure 3 14: Class 2 Device Recall Blue Belt Technologies 50
Figure 3 15: Class 2 Device Recall Hansen Medical 51
Figure 3 16: Class 2 Device Recall Hansen Medical 51
Figure 3 17: Class 2 Device Recall Hansen Medical 51
Figure 3 18: Class 2 Device Recall Intuitive Surgical 52
Figure 3 19: Class 2 Device Recall Intuitive Surgical 52
Figure 3 20: Class 2 Device Recall Intuitive Surgical 52
Figure 3 21: Class 2 Device Recall Intuitive Surgical 53
Figure 3 22: Class 2 Device Recall Intuitive Surgical 53
Figure 3 23: Class 2 Device Recall Intuitive Surgical 53
Figure 3 24: Class 2 Device Recall Intuitive Surgical 54
Figure 3 25: Class 2 Device Recall Intuitive Surgical 54
Figure 3 26: Class 2 Device Recall Intuitive Surgical 55
Figure 3 27: Class 2 Device Recall Intuitive Surgical 55
Figure 3 28: Class 2 Device Recall Intuitive Surgical 56
Figure 3 29: Class 2 Device Recall Intuitive Surgical 57
Figure 3 30: Class 2 Device Recall Intuitive Surgical 57
Figure 3 31: Class 2 Device Recall Intuitive Surgical 57
Figure 3 32: Class 2 Device Recall Intuitive Surgical 58
Figure 3 33: Class 2 Device Recall Intuitive Surgical 58
Figure 3 34: Class 2 Device Recall Intuitive Surgical 59
Figure 3 35: Class 2 Device Recall Intuitive Surgical 59
Figure 3 36: Class 2 Device Recall Intuitive Surgical 59
Figure 3 37: Class 2 Device Recall Intuitive Surgical 60
Figure 3 38: Class 2 Device Recall Intuitive Surgical 60
Figure 3 39: Class 2 Device Recall Intuitive Surgical 60
Figure 3 40: Class 2 Device Recall Intuitive Surgical 61
Figure 3 41: Class 2 Device Recall Intuitive Surgical 61
Figure 3 42: Class 2 Device Recall Intuitive Surgical 62
Figure 3 43: Class 2 Device Recall Intuitive Surgical 63
Figure 3 44: Class 2 Device Recall Intuitive Surgical 63
Figure 3 45: Class 2 Device Recall Intuitive Surgical 64
Figure 3 46: Class 2 Device Recall Intuitive Surgical 64
Figure 3 47: Class 2 Device Recall Intuitive Surgical 65
Figure 3 48: Class 2 Device Recall Intuitive Surgical 65
Figure 3 49: Class 2 Device Recall Intuitive Surgical 66
Figure 3 50: Class 2 Device Recall Intuitive Surgical 66
Figure 3 51: Class 2 Device Recall Intuitive Surgical 66
Figure 3 52: Class 2 Device Recall Intuitive Surgical 67
Figure 3 53: Class 2 Device Recall Intuitive Surgical 67
Figure 3 54: Class 2 Device Recall Intuitive Surgical 67
Figure 3 55: Class 2 Device Recall Intuitive Surgical 68
Figure 3 56: Class 2 Device Recall Intuitive Surgical 68
Figure 3 57: Class 2 Device Recall Intuitive Surgical 68
Figure 3 58: Class 2 Device Recall Intuitive Surgical 68
Figure 3 59: Class 2 Device Recall Intuitive Surgical 69
Figure 3 60: Class 2 Device Recall Intuitive Surgical 69
Figure 3 61: Class 2 Device Recall Intuitive Surgical 69
Figure 3 62: Class 2 Device Recall MAKO Surgical/Stryker 70
Figure 3 63: Class 2 Device Recall MAKO Surgical/Stryker 70
Figure 3 64: Class 2 Device Recall MAKO Surgical/Stryker 70
Figure 3 65: Class 2 Device Recall MAKO Surgical/Stryker 71
Figure 3 66: Class 2 Device Recall MAKO Surgical/Stryker 71
Figure 3 67: Class 2 Device Recall MAKO Surgical/Stryker 71
Figure 3 68: Class 2 Device Recall OMNIlife Science, Inc 72
Figure 3 69: Class 2 Device Recall OMNIlife Science, Inc 72
Figure 3 70: Class 2 Device Recall OMNIlife Science, Inc 72
Figure 3 71: Class 2 Device Recall OMNIlife Science, Inc 73
Figure 3 72: Class 2 Device Recall OMNIlife Science, Inc 73
Figure 3 73: Endoscopic Evaluation of Late Rectal Injury Following CyberKnife Radiosurgery for Prostate Cancer 75
Figure 3 74: CyberKnife Stereotactic Radiosurgery for Low and Intermediate Risk Prostate Cancer 75
Figure 3 75: A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate Tumors 76
Figure 3 76: Study To Establish Maximum Tolerated Dose (MTD) of Cyberknife in Patients 76
Figure 3 77: A Phase II Trial of CyberKnife Radiosurgery to Perioptic Tumors 77
Figure 3 78: An Effectiveness and Toxicity of CyberKnife Based Radiosurgery for Parkinson Disease 78
Figure 3 79: CyberKnife Stereotactic Accelerated Partial Breast Irradiation (SAPBI) (CK-SAPBI) 78
Figure 3 80: Safety and Efficacy Study of Five-fraction Stereotactic Body Radiation Therapy 79
Figure 3 81: A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer 79
Figure 3 82: Stereotactic Radiosurgery for Soft Tissue Sarcoma 80
Figure 3 83: A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma 80
Figure 3 84: Evaluation of Clinical Outcomes in Robotic-Assisted Inguinal Hernia Repair 81
Figure 3 85: A Retrospective Multicenter Investigation of the Use of the da Vinci® Surgical System 81
Figure 3 86: Cosmesis, Patient Satisfaction and Quality of Life After da Vinci 82
Figure 3 87: Robotic-assisted Versus Laparoscopic Sigmoid Resection 82
Figure 3 88: Prospective Investigation of Robotic Single-port System 83
Figure 3 89: Clinical Outcomes of Knee Replacement 84
Figure 3 90: A Trial Evaluating TKR Compared to BKR Performed Using Stryker's Mako Robot 84
Figure 3 91: Robotic Arm Assisted Total Knee Arthroplasty 85
Figure 3 92: Outcomes of Robotic Total Hip Arthroplasty 85
Figure 3 93: Clinical and Economic Comparison of Robot Assisted Versus Manual Knee Replacement 86
Figure 3 94: Prospective, Observational Registry of Renaissance-guided Spine Surgeries 87
Figure 3 95: Clinical Trial of Minimally Invasive Robotic Spine Surgery 87
Figure 3 96: Robotic vs. Freehand Corrective Surgery for Pediatric Scoliosis (PEDSCOLI) 88
Figure 3 97: ADDRESS - Adult Deformity Robotic vs. Freehand Surgery to Correct Spinal Deformity 88
Figure 3 98: MIS ReFRESH: Robotic vs. Freehand Minimally Invasive Spinal Surgeries 89
Figure 3 99: A Post-Market Clinical Trial for Access and Visualization 90
Figure 3 100: Robotic-assisted Pedicule Screw Placement (ARASS) 91
Figure 4 1: Minimally Invasive Surgery Robotic Device Market, India, 2013 – 2023 (US$) 96
Figure 4 2: Minimally Invasive Surgery Robotic Device Market, India, 2013 – 2023 (IN₹) 97
Figure 4 3: Drivers and Limiters, Minimally Invasive Surgery Robotic Device Market, India, 2016 100
Figure 4 4: Leading Competitors, Orthopedic Navigation System Market, India, 2016 101
Figure 4 5: Robotic Assisted Orthopedic Surgery Market, India, 2013 – 2023 (US$) 104
Figure 4 6: Robotic Assisted Orthopedic Surgery Market, India, 2013 – 2023 (IN₹) 105
Figure 4 7: Drivers and Limiters, Robotic Assisted Orthopedic Surgery Market, India, 2016 109
Figure 4 8: Leading Competitors, Robotic Assisted Orthopedic Surgery Market, India, 2016 111
Figure 5 1: Drivers and Limiters, Robotic Radiosurgery Device Market, India, 2016 118
Figure 7 1: Robotic Assisted Surgery Press Release Summary 123
Figure 7 2: Surgical Navigation Press Release Summary 402
Brainlab
Medtronic
Stryker
Aesculap Inc.
Medtech Surgical
Mazor Robotics
Intuitive Surgical
Accuray
Hansen Medical
Renishaw
Corindus Vascular Robotics
Catheter Precision
Stereotaxis
Smith & Nephew